Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
A.2.5.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.600EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
P.1.12 (Gamma)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.525 (Eta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.6 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.5.5 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
P.1.7 (Gamma)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.119.1 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.25.2 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.122.6 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.621.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.39.2 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.125 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.103.1 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.92 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.122.4 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.101 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.1.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BT.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BE.1.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FS.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.54EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BF.29EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.2.29EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
N.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
P.1.15 (Gamma)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.348EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.575EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
C.26EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
P.1.14 (Gamma)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
P.1.7.1 (Gamma)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
P.1.2 (Gamma)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.112 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
P.1.10 (Gamma)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
A.2.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.102 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.124 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.46.6 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.43.3 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.1.33EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CP.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.45EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BN.1.7EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BF.5.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.41EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.75.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.1.20EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CR.1.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
DV.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.1.14EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used